Cabaletta Bio (CABA) Total Liabilities (2018 - 2025)

Cabaletta Bio's Total Liabilities history runs 8 years deep, the most recent figure standing at $53.0 million for Q4 2025.

• On a quarterly basis, Total Liabilities rose 62.12% year-over-year to $53.0 million in Q4 2025; TTM through Dec 2025 was $53.0 million, a 62.12% increase from a year earlier, with the FY2025 full-year figure at $53.0 million, up 62.12% from the prior year.
• Total Liabilities advanced to $53.0 million in Q4 2025 per CABA's latest filing, from $50.3 million in the prior quarter.
• Across five years, Total Liabilities topped out at $122.6 million in Q3 2021 and bottomed at $8.4 million in Q4 2021.
• The 5-year median for Total Liabilities is $38.1 million (2024), against an average of $50.5 million.
• Across the five-year window, Total Liabilities sank 92.7% in 2021 and surged 157.1% in 2025, its largest moves.
• Year by year, Total Liabilities stood at $8.4 million in 2021, then soared by 48.54% to $12.4 million in 2022, then surged by 40.2% to $17.5 million in 2023, then jumped by 87.43% to $32.7 million in 2024, then surged by 62.12% to $53.0 million in 2025.
• Per Business Quant, the three latest CABA Total Liabilities figures stand at $53.0 million (Q4 2025), $50.3 million (Q3 2025), and $46.0 million (Q2 2025).